September 12, 2012 – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
We want absolutes; things we can depend on; certainties in an unfortunately uncertain world. It’s the kind of faith we ...
August 27, 2012 — The growth rate of positron emission tomography (PET) and PET/computed tomography (CT) medical imaging ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...
August 24, 2012 — West Physics Consulting, a national provider of medical and health physics consulting and testing ...
August 21, 2012 — Siemens Healthcare announced that its syngo.PET Amyloid Plaque proprietary software has received ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...
August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...
August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...
When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the Lake ...
July 27, 2012 — Siemens Healthcare (booth 707) will be at the 2012 Annual Meeting of the American Association of ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...
The last 20 years have brought about great advances in breast cancer detection and treatment. Among them has been the ...
July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...
July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron ...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...
June 20, 2012 — The Society of Nuclear Medicine’s (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213 ...
June 15, 2012 — Data presented at the Society for Nuclear Medicine (SNM) Annual Meeting shows that uptake of the ...
June 15, 2012 — Several groundbreaking studies on the Naviscan PET scanner, the breast application for which is positron ...
September 12, 2012 